PI
HAE icon

Putnam Investments’s Haemonetics HAE Stock Holding History

Putnam Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-41,256
Closed -$3.6M – 819
2020
Q3 		$3.6M Hold
41,256
– – 0.01% 537
2020
Q2 		$3.69M Sell
41,256
-140
-0.3% -$14.1K 0.01% 518
2020
Q1 		$4.13M Sell
41,396
-120
-0.3% -$13K 0.01% 476
2019
Q4 		$4.77M Buy
41,516
+180
+0.4% +$21.8K 0.01% 515
2019
Q3 		$5.21M Buy
+41,336
New +$5.25M 0.01% 494
2014
Q2 		– Sell
-22,657
Closed -$739K – 1482
2014
Q1 		$739K Sell
22,657
-17,828
-44% -$681K ﹤0.01% 1270
2013
Q4 		$1.71M Sell
40,485
-605
-1% -$24.9K ﹤0.01% 1081
2013
Q3 		$1.64M Sell
41,090
-10,587
-20% -$444K ﹤0.01% 1113
2013
Q2 		$2.14M Buy
+51,677
New +$2.09M 0.01% 1034

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Putnam Investments's HAE Position: Q4 2020 in Review

Putnam Investments sold out of Haemonetics (HAE) in Q4 2020, closing a stake of 41,256 shares — an estimated $3.6M sold.

Putnam Investments first reported a position in HAE in Q2 2013 and held it in 9 quarters. The position peaked at $5.21M in Q3 2019. 286 funds tracked by Wall St. Rank hold HAE as of Q4 2020.

  • Putnam Investments reported no remaining Haemonetics position as of Q4 2020 after selling out during the quarter.
  • Putnam Investments sold 41,256 Haemonetics shares in Q4 2020, an estimated $3.6M.
  • Putnam Investments first reported a position in Haemonetics in Q2 2013 and held it in 9 quarters.
  • Putnam Investments's Haemonetics position peaked at $5.21M in Q3 2019.
  • 286 funds tracked by Wall St. Rank held Haemonetics as of Q4 2020.

Based on Putnam Investments's 13F filing for Q4 2020, filed 16 Feb 2021.